[Organoids for Oncology] Early adopters of innovative methods

[Organoids for Oncology] Early adopters of innovative methods

Collaboration offers

Information

InnoSer is looking for early adopters of the innovative PDX/O platform used in oncology research. Read about our opinion piece and get in touch with us to discuss collaboration possibilities! Keywords: pdxo, cancer, drug development, preclinical
URL
https://www.innoserlaboratories.com/blog/personalized-medicine-early-patient-data/
InnoSerFounded in 2012, InnoSer is an innovative and dynamic contract research organization (CRO) supporting discovery and preclinical development of drugs. InnoSer’s offerings include PDXO screening platform for oncology, ADPKD mouse model for nephrology, and validated midbrain organoid model for Parkinson’s disease. It also provides pathology, in-vivo imaging and genetically engineered mice model services like colony management, cryopreservation, sanitation/rederivation. Visit our kfg page to learn more www.innoserlaboratories.com/kfg2020

Join the event!